微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 8.21% | -8.06% | 80.04% | 12/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 4.56% | -10.24% | -72.78% | 13/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 16.75% | 44.65% | 22.35% | 7/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 13.69% | -0.87% | 53.3% | 11/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 8.93% | -0.33% | 75.79% | 15/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 5.08% | -9.29% | -56.13% | 10/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 11.58% | -33.75% | -16.15% | 22/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 13.81% | -15.22% | 54.13% | 11/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.96% | -17.11% | 60% | 13/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 5.6% | -15.28% | -67.96% | 5/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 17.48% | -1.52% | 7.31% | 5/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 16.29% | 14.16% | 50.69% | 4/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 10.81% | 21.05% | 63.54% | 3/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 6.61% | 28.35% | -62.76% | 3/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 17.75% | 35.29% | 24.39% | 11/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.27% | 18.33% | 59.8% | 13/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.93% | 11.9% | 73.4% | 17/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.15% | -0.58% | -60.75% | 13/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 13.12% | -13.74% | 8.79% | 29/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 12.06% | -8.36% | 51.13% | 21/157 | 4.46% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 7.98% | -3.27% | 54.05% | 26/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.18% | 16.67% | -65.94% | 10/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 15.21% | 4.68% | 15.58% | 31/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.16% | 5.7% | 59.52% | 22/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.25% | 13.95% | 85.81% | 29/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 4.44% | 14.73% | -69.44% | 17/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 14.53% | 11.77% | 16.71% | 32/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 12.45% | 14.22% | 71.96% | 19/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 7.24% | 11.04% | 87.08% | 27/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.87% | 9.94% | -70.23% | 19/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 13% | 34.3% | 19.27% | 36/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.9% | 33.25% | 67.18% | 20/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 6.52% | 32.25% | 85.23% | 27/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.52% | 23.51% | -63.64% | 19/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.68% | -14.18% | 18.34% | 50/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.18% | -13.99% | 65.92% | 41/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.93% | -24.27% | 72.98% | 42/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.85% | -16.42% | -74.73% | 30/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 11.28% | -18.38% | 18.61% | 45/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.51% | -10.11% | 46.08% | 26/157 | 5.64% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 6.51% | -31.97% | 90.91% | 28/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.41% | 2% | -75.33% | 22/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |